Lexicon Pharma

$4.64 0.00% ($0.00)

Get ready to invest

About Lexicon Pharma

Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of treatments for human disease. The Company's drug programs include Sotagliflozin and LX9211. The Company also has a number of additional compounds into various stages of clinical and preclinical development. The Company’s LX9211 is an orally-delivered small molecule compound that is being developed for the treatment of neuropathic pain. The Company intends to initiate a Phase IIa clinical trial evaluating the safety and tolerability of LX9211 and its effects on diabetic peripheral neuropathic (DPN) pain. Its Sotagliflozin is an orally-delivered small molecule compound that is being developed for the treatment of type I diabetes and type II diabetes, heart failure and chronic kidney disease.

Popular Stocks	Price	Change
AMC Entertainment AMC	$59.26 3.26%	3.26%
W ContextLogic WISH	$11.4 4.3%	4.3%
Apple AAPL	$130.46 0.54%	0.54%
C Clean Energy Fuels CLNE	$11.78 1.75%	1.75%
Bank of America BAC	$38.78 0.26%	0.26%
NIO NIO	$46.91 0.89%	0.89%
General Electric GE	$12.78 0%	0%
Ford F	$14.52 0.41%	0.41%
Palantir PLTR	$25.37 0.08%	0.08%
AT&T T	$28.65 0.17%	0.17%